ScholarDeck

Randomized trialAsia-Pacific journal of ophthalmology (Philadelphia, Pa.) · 2026

Slowing myopia progression with a novel spectacle lens - 1-year, randomized double-masked, cross-over clinical trial.

Linlin Du, Padmaja Sankaridurg, Min Tong … Xiangui He

Read paper

OphthalmologyRandomized trial

Novel spectacle lens slowed myopia progression more than standard single-vision lenses.

Slowing myopia progression with a novel spectacle lens - 1-year, randomized double-masked, cross-over clinical trial.

Linlin Du … Xiangui He

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) · 2026

Purpose

To evaluate the effectiveness of test spectacle lens in slowing myopia progression as compared to single vision (single vision) spectacle (spectacle).

Methods

Enrolled participants were randomly assigned to wear either single vision or test spectacle (n = 60 each group).

n = 120 children

Results

children's eyes needing stronger correction increased less over six months

MD 0.32 (95% CI 0.21 to 0.43)

null 0

0.21

0.43

CI excludes the null - significant

More results

Myopia progression was significantly slower with test spectacle during both stages.

During stage II, myopia progressed slower by 0.25D (0.15, 0.36) and 0.11 mm (0.07, 0.14) (P < 0.001) with test spectacle.

More results

Progression with single vision during stage I and stage II did not differ significantly (SE: -0.42 ± 0.31D vs -0.51 ± 0.30D, p = 0.119; AL: 0.19 ± 0.11 mm vs 0.22 ± 011 mm, P = 0.182).

“

Conclusion

Test spectacles significantly slow myopia in majority of eyes in 6 months and no statistically significant rebound signal was detected during the observation period.

Post

Slowing myopia progression with a novel spectacle lens - 1-year, randomized double-masked, cross-over clinical trial.

Novel spectacle lens slowed myopia progression more than standard single-vision lenses.

Related papers